ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer

Zhou, Jianfu; Wang, Yuliang; Wu, Dinglan; Wang, Shusheng; Chen, Zhiqiang; Xiang, Songtao*; Chan, Franky Leung*广州中医药大学; 南方医科大学
Oncogene2021-4-15DOI: 10.1038/s41388-021-01737-1
16被引9阅读
引用收藏
分享

摘要

Castration-resistant prostate cancer (CRPC) almost invariably occurs after androgen-deprivation therapy (ADT) for the advanced metastatic disease. It is generally believed that among multiple mechanisms and signaling pathways, CRPC is significantly driven by the reactivation of androgen receptor (AR) signaling in ADT-treated patients with castrate levels of androgen, partially at least mediated by the androgen biosynthesis within the tumor, also known as intratumoral or intraprostatic androgen biosynthesis. Steroidogenic enzymes, such as CYP11A1, CYP17A1, HSD3B1, AKR1C3 and SRD5A, are essential to catalyze the conversion of the initial substrate cholesterol into potent androgens that confers the CRPC progression. Accumulating evidences indicate that many steroidogenic enzymes are upregulated in the progression setting; however, little is known about the dysregulation of these enzymes in CRPC. Orphan nuclear receptors (ONRs) are members of the nuclear receptor superfamily, of which endogenous physiological ligands are unknown and which are constitutively active independent of any physiological ligands. Studies have validated that besides AR, ONRs could be the potential therapeutic targets for prostate cancer, particularly the lethal CRPC progression. Early studies reveal that ONRs play crucial roles in the transcriptional regulation of steroidogenic enzyme genes. Notably, we and others show that three distinct ONRs, including liver receptor homolog-1 (LRH-1, NR5A2), steroidogenic factor 1 (SF-1, AD4BP, NR5A1) and estrogen-related receptor alpha (ERR alpha, NR3B1), can contribute to the CRPC progression by promotion of the intratumoral androgen synthesis via their direct transcriptional regulation on multiple steroidogenic enzymes. This review presents an overview of the current understanding on the intratumoral androgen biosynthesis in CRPC, with a special focus on the emerging roles of ONRs in this process.

学科与关键词

关键词
STEROIDOGENIC FACTOR-ITRANSCRIPTIONAL REGULATIONERR-ALPHAINCREASED SURVIVALEMERGING ROLESCOUP-TFIIHOMOLOG 1EXPRESSIONLRH-1METABOLISM
相关
加载中…
  • Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glance
    Jian, Jingang; Wang, Xin'an; Zhang, Jun; Zhou, Chenchao; Hou, Xiaorui; Huang, Yuhua; Hou, Jianquan*; Lin, Yuxin*; Wei, Xuedong*Frontiers in Endocrinology, 2024, 15: 1360430.
  • Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer
    Lv, Shidong; Song, Qiong; Chen, Guang; Cheng, Erdong; Chen, Wei; Cole, Ryan; Wu, Zeyu; Pascal, Laura E.; Wang, Ke; Wipf, Peter; Nelson, Joel B.; Wei, Qiang; Huang, Wenhua*; Wang, Zhou*Journal of Clinical Investigation, 2021, 131(4): e141335.被引 34
  • LNCaP Atlas: Gene expression associated with in vivo progression to castration-recurrent prostate cancer
    Romanuik, Tammy L.; Wang, Gang; Morozova, Olena; Delaney, Allen; Marra, Marco A.; Sadar, Marianne D.*BMC Medical Genomics, 2010, 3: 43.被引 79
查看全部 →

发表信息

论文状态
公开发表
期刊
Oncogene
发表日期
2021-04-15
卷期
第 40 卷, 第 15 期
页码
2625-2634
DOI
10.1038/s41388-021-01737-1
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81774067, 81802575, 82072830, 81872283]; Medical Science and Technology Research Fund of Guangdong Province [A2020239]; Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine [YN2016MJ03]; Guangdong-Hong Kong collaborative innovation projects from the Department of Science and Technology of Guangdong Province [2017A050506042]; Guangdong Provincial Hospital of Chinese Medicine [YN2018HK02]; General Research Fund, Research Grants Council of Hong Kong [461009, 2140789, 14100914, 14107116, 14110918]; Health and Medical Research Fund [02130066]; Food and Health Bureau of Hong Kong; Eternal Flame Scholar Programme of Guangzhou University of Chinese Medicine

作者

  • Z

    Zhou, Jianfu (第一作者)

    2 · guangzhou univ chinese med · chinese univ hong kong

  • W

    Wang, Yuliang

    chinese univ hong kong

查看全部 7 位作者收起作者
  • W

    Wu, Dinglan

    southern med univ

  • W

    Wang, Shusheng

    2 · guangzhou univ chinese med

  • C

    Chen, Zhiqiang

    2 · guangzhou univ chinese med

  • X

    Xiang, Songtao (通讯)

    2 · guangzhou univ chinese med

  • C

    Chan, Franky Leung (通讯)

    chinese univ hong kong

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417